AI and Polypharmacy in Older Adults: A Promising Combination

Oct 16, 2026 · Published in: Healthcare (Basel, Switzerland)

📅 Journal publication: Oct 1, 2026 · Last updated: Oct 18, 2026

Background Information

AI could revolutionize medication safety for polypharmacy in older adults.

Polypharmacy in older adults increases the risk of adverse outcomes, requiring careful medication optimisation. Evidence supports improved prescribing quality via AI and pharmacist-led reviews, though clinical outcomes like reduced falls are less consistent. AI tools may enhance medication safety but require robust data and validation; European models offer insights for integration. Medication optimisation should integrate AI with comprehensive assessments and multidisciplinary reviews.

📊 Deep Analysis Available

Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.

Subscribe for Full Access →

Authors: Aro R, Wojszel ZB, Duez P, Lecron F, Patris S

Citation: Aro R, Wojszel ZB, Duez P, et al. A Narrative Review of Medication Optimisation in Older Adults with Polypharmacy: From Structured Medication Review to AI-Enabled Medication Safety. Healthcare (Basel, Switzerland). 2026;14(19). doi:10.3390/healthcare14193240

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓

Reviewed by a licensed pharmacist

Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.

Accurate and up-to-date information is our highest priority.

If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.

Suggest a correction Request a topic

Thanks for the feedback!

Deep Analysis Pending

The deep analysis for this article is pending full-text access. We only publish a full clinical breakdown once we have the complete paper, not just the abstract. The PubMed abstract is linked above in the meantime.